Prolonged progesterone treatment of endometrial epithelial cells modifies the effect of estradiol on their sensitivity to oxytocin.
Estradiol (E2), progesterone (P4), and oxytocin (OT) are important for the initiation of luteolysis in ruminants but the mechanisms involved are still poorly understood. The objective of this study was to determine if duration of exposure of bovine endometrial epithelial cells to P4 affected the response of the cells to E2. Endometrial epithelial cells, from cows at Days 1-3 of the estrous cycle, were cultured for 10, 17, and 21 days in the presence or absence of P4 (100 ng ml(-1)). After culture, each group of cells was incubated for a further 6, 12, 24 or 48 h with or without E2 (100 pg ml(-1)) and then incubated for 6 h with different doses of OT (2, 20, and 200 ng ml(-1)). E2 enhanced OT-stimulated PGF2 alpha secretion in cells cultured with P4 for 17 or 21 days, with a maximum effect after 24-h exposure, but not in cells cultured with P4 for 10 days. To determine the mechanism of action of E2, COX-1 and COX-2 were measured by Western blotting and OTR number was measured by saturation analysis. OT increased COX-2 (P<0.05), but there was no significant effect of E2 on the expression of either COX-1 or COX-2. E2 did, however, increase (P<0.001) the OTR number in cells cultured with P4 for 21 days, whereas it inhibited OTR in cells cultured for 10 days. These data show that E2 can stimulate PGF2 alpha secretion by increasing OTR expression in bovine endometrial cells in vitro, but only after exposure to P4.
Kombé
A
A
Centre de Recherche en Reproduction Animale, Faculté de Médecine Vétérinaire, Université de Montréal, 3200 Rue Sicotte, St-Hyacinthe, Que., Canada J2S 7C6.
Sirois
J
J
Goff
A K
AK
D000818:Animals; D002417:Cattle; D015237:Dinoprost / Q000378:metabolism; D004347:Drug Interactions; D004717:Endometrium / Q000737:chemistry / Q000166:cytology* / Q000187:drug effects; D004847:Epithelial Cells / Q000737:chemistry / Q000187:drug effects; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D010121:Oxytocin / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D018045:Receptors, Oxytocin / Q000096:biosynthesis* / Q000187:drug effects; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects
D018045:Receptors, Oxytocin; D011374:Progesterone; D004958:Estradiol; D010121:Oxytocin; D015237:Dinoprost